Arrowhead Pharmaceuticals | 144:拟议出售证券
05/02 14:44 (美东)
Arrowhead Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(10.01%)
04/10 14:08 (美东)
Arrowhead Pharmaceuticals | 4:持股变动声明-高管 Hamilton James C
04/03 18:09 (美东)
Arrowhead Pharmaceuticals | 144:拟议出售证券
04/01 16:33 (美东)
Arrowhead Pharmaceuticals | 4:持股变动声明-董事 Lu Hongbo
03/20 19:08 (美东)
Arrowhead Pharmaceuticals | 8-K:重大事件
03/19 16:42 (美东)
Arrowhead Pharmaceuticals | 3:首次持股声明-董事 Lu Hongbo
03/18 19:01 (美东)
Arrowhead Pharmaceuticals | 8-K/A:重大事件(修正)
03/18 15:37 (美东)
Arrowhead Pharmaceuticals | 4:持股变动声明-高管 Myszkowski Kenneth Allen
03/08 17:57 (美东)
Arrowhead Pharmaceuticals | 144:拟议出售证券
03/06 17:35 (美东)
Arrowhead Pharmaceuticals | S-8:员工福利计划证券登记
02/28 22:29 (美东)
Arrowhead Pharmaceuticals | DEFA14A:其他
02/27 17:15 (美东)
Arrowhead Pharmaceuticals | 8-K:重大事件
02/22 14:40 (美东)
Arrowhead Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(9.93%)
02/13 17:00 (美东)
Arrowhead Pharmaceuticals | 10-Q:季度报表
02/06 16:19 (美东)
Arrowhead Pharmaceuticals | 8-K:Arrowhead Pharmicals公布2024财年第一季度业绩
02/06 16:08 (美东)
Arrowhead Pharmaceuticals | 4:持股变动声明-高管 Anzalone Christopher Richard
02/02 17:27 (美东)
Arrowhead Pharmaceuticals | 144:拟议出售证券
01/31 17:03 (美东)
Arrowhead Pharmaceuticals | ARS:年度报告
01/29 14:48 (美东)
Arrowhead Pharmaceuticals | DEF 14A:股东委托书决议
01/26 17:32 (美东)
暂无数据
暂无数据